Zseraldin Metyovinyi

Dr. Zseraldin Metyovinyi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2024 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
DPDóra Plázár
Dóra Plázár
ZMZseraldin Metyovinyi
Zseraldin Metyovinyi
MMMárta Medvecz
Márta Medvecz
FRFanni Rencz
Fanni Rencz
Objectives Limited evidence is available about the content validity of the EQ-5D-5L in rare skin fragility disorders. Previous research has demonstrated that the skin irritation and self-confidence additional dimensions (bolt-ons) improve the content validity of the EQ-5D-5L in psoriasis and atopic dermatitis. Our aim was to investigate the content validity of the EQ-5D-5L and the two bolt-ons in Darier’s disease and Hailey-Hailey disease. Methods In 2023, we conducted qualitative, semi-structured interviews with 15 adult patients at a university dermatology clinic. Patients completed the EQ-5D-5L with two bolt-ons using a think-aloud technique. We used probing questions to explore the relevance, comprehensiveness and comprehensibility. Thematic analysis was applied to analyze the transcripts from the interviews. Results Most patients found both the EQ-5D-5L and the two bolt-ons comprehensible and relevant to their disease. All patients preferred the EQ-5D-5L with the two bolt-ons over the EQ-5D-5L alone. Twelve potential missing concepts were identified after the EQ-5D-5L + bolt-ons, but only financial impact and sex life were identified by more than one patient. Only one patient reported a conceptual overlap between the skin irritation bolt-on and the pain/discomfort dimension. Conclusions Our findings suggest that there is no actionable evidence indicating gaps in the content validity of the EQ-5D-5L with two bolt-ons in Darier’s and Hailey-Hailey disease. Future studies are encouraged to conduct quantitative psychometric testing of the bolt-ons in this and other chronic dermatological patient populations.

7 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KKKrisztina Kerekes
Krisztina Kerekes
MBMehdi Boostani
Mehdi Boostani
ZMZseraldin Metyovinyi
Zseraldin Metyovinyi
Norbert KissNorbert Kiss
Norbert Kiss
MMMárta Medvecz
Márta Medvecz
Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by cutaneous and subcutaneous neurofibromas, which impact quality of life. Dermoscopy-guided high-frequency ultrasound (DG-HFUS) integrates dermoscopy with 33 MHz ultrasound, enabling precise lesion localization and reproducible measurements. Objective: To characterize neurofibromas in NF1 patients using DG-HFUS and identify imaging parameters for diagnosis, monitoring, and treatment planning. Methods: 14 genetically confirmed NF1 patients underwent DG-HFUS imaging (Dermus SkinScanner). 100 neurofibromas were assessed for size, location, shape, contours, surface, echogenicity, global echogenicity, and posterior acoustic features. Results: Lesions were dermal (79%) or subcutaneous (21%), round (28%), ovoid (63%), or spiked (9%). Mean vertical and lateral diameters were 5.37 ± 2.66 mm and 2.28 ± 1.39 mm. All were hypoechoic; 62% homogeneous, 38% heterogeneous. Margins were well-defined in 57% and poorly defined in 43%. Posterior enhancement occurred in 3% and shadowing in 10%. Conclusions: DG-HFUS provides a detailed, reproducible assessment of neurofibromas, supporting differential diagnosis, surgical planning, and longitudinal monitoring. The evaluated imaging parameters offer objective insights for optimizing NF1 management. Future developments, including 3D reconstruction and AI-assisted analysis, may further enhance its clinical utility.

15 July 2025 in JAAD International
Verified
Journal Article
Open access
ZMZseraldin Metyovinyi
Zseraldin Metyovinyi
ISIstván Szondy
István Szondy
NKNorbert Kiss
Norbert Kiss
EOEszter Ostorházi
Eszter Ostorházi
ZMZseraldin Metyovinyi
Zseraldin Metyovinyi
Inherited ichthyoses (iI) are a heterogeneous group of keratinization disorders, whose microbiome composition and the role of dysbiosis remain largely unexplored. Characterization of the skin microbiome profile in iI and exploration of the significance of dysbiosis based on the literature. A systematic search was performed across MEDLINE, Embase, Cochrane Library, Web of Science, and Scopus on 23 September 2024. Studies with culture-based and molecular diagnostic methods were included. 1923 records were retrieved, and 13 met our inclusion criteria. The studies identified focused on non-syndromic and syndromic ichthyosis genotypes. Significant dysbiosis was observed in iI subtypes, with altered alpha and beta diversity. Subtype-specific alterations included elevated levels of pathogenic bacteria, such as Staphylococcus aureus, while the relative abundances of commensal microbes, including Cutibacterium acnes and Malassezia globosa, were significantly reduced in all ichthyoses examined. These changes were closely related to clinical severity, transepidermal water loss, and elevated proinflammatory cytokines. The heterogeneity of studies is a limitation. These findings emphasize the distinct microbiome profiles of different iI subtypes, marked by an imbalance, enrichment of pathogenic microorganisms, and a reduction in protective microbes. This dysbiosis is linked to disease severity and inflammation.

12 February 2026 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
ZMZseraldin Metyovinyi
Zseraldin Metyovinyi
DPDóra Plázár
Dóra Plázár
KBKrisztina Becker
Krisztina Becker
MMMárta Medvecz
Márta Medvecz
FRFanni Rencz
Fanni Rencz
Purpose: Epidermal differentiation disorders (EDDs) are rare genetic skin disorders that significantly impact patients’ health and wellbeing. This study assessed the content validity of two experimental EuroQol instruments (EQ-5D-5Lbolt-ons and EQ-HWB-9) and explored potential endpoint options for a visual analogue scale (VAS) for EQ-HWB-9 in this population. Methods: Semi-structured interviews were conducted with 20 adult patients with EDDs at a university dermatology clinic (2024–2025). Participants completed the EQ-5D-5L with skin irritation and self-confidence bolt-ons and EQ-HWB-9 using a think-aloud protocol. Probing questions explored item relevance, missing concepts, and comprehensibility. An EQ-HWB VAS with endpoints blanked out was also presented for feedback. Results: Participants found both instruments generally comprehensive, understandable, and relevant for EDD. The EQ-5D-5L with bolt-ons was considered suitable for measuring health- and disease-related aspects (e.g., skin irritation bolt-on was the most relevant item for all but one patients), while the EQ-HWB-9 was seen as relevant to measure broader life impacts. Three participants suggested combining the EQ-HWB-9 loneliness item with others, and three participants recommended splitting the sadness/depression item. One participant noted missing social/romantic relationship items in both instruments. Overall, 32 different concepts were proposed as EQ-HWB VAS endpoint labels, including both health-related and broader wellbeing concepts, such as overall feeling, mood, quality of life, and harmony. Conclusion: Both the EQ-5D-5L with bolt-ons and EQ-HWB-9 demonstrated acceptable content validity in this genetic disease population. Our findings provide useful input for finalizing these experimental instruments and offer the first exploratory qualitative results about potential endpoints for an EQ-HWB VAS.